Evidence map›Paper›PMID 37876445›Full record

ArticleHeliyon2023

Prognostic model construction and target identification of Si-Wu-Tang against breast cancer.

Zeye Zhang, Zexin Zhang, Jinqin Song, Wenfeng Wu, Yiqi Chen, Jing Li, Yongchen Wang, Piwen Zhao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Zeye ZhangSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.
Zexin ZhangThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Jinqin SongSchool of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Wenfeng WuThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Yiqi ChenThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Jing LiThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Yongchen WangThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Piwen ZhaoSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.
Guangzhou University of Chinese Medicine · CNBeijing University of Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The targets and mechanisms of Si-Wu-Tang (SWT) against (Breast cancer) BRCA were identified and a survival model and nomogram was construted by network pharmacology, bioinformatic analysis and

Indexed as

Bioinformatics analysisBreast cancerNetwork pharmacologySi-Wu-Tang

Identifiers

PMID37876445
PMCPMC10590855
OpenAlexW4387579622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.